Enovis Logo
change profile

Click the button below to go to the homepage and view the site as a Patient.

!news_events_title

07 July 2026

Enovis 1st Worlwide Innovations influencing shoulder arthroplasty​

During the last 6 months we have reviewed together great milestones that represent Enovis innovations in the orthopaedic industry. It has been a long journey, so let's recap!​

Do you know...that RM Technology, first used in the hip in 1983, provides an isoelastic ongrowth surface with no solid metal structure? [1]​

Do you know...that rTSA lateralisation helps restoring soft tissue tensioning and avoiding scapular notching since the first custom RSP glenoid in 1998?[2]​

Do you know... that ceramic, with its low wear rate and high strenght,[3,4] has been developed and produced in house since year 2000? ​

Do you know...that since 2002, SMR has been the 1st modular convertible shoulder platform and the 1st receiving a 10A ODEP in 2018?[5]​

Do you know...that the inverted bearings configuration in RSA, helping avoiding PE wear and hence biological notching[6], was included in SMR portfolio since 2005 and in the Affinis Inverse one since 2007?​

Do you know ...that the excellent properties of vitamys (blended VEPE)[7] entered the hip portfolio in 2009 and the shoulder one in 2014?​

Do you know...that SMR TT Hybrid Glenoid, launched in 2017, has been the 1st convertible hybrid glenoid component featuring a 3D printed TT central peg?​

Do you know...that Affinis Short has received the first ODEP 10A* in 2024 [5] and is the 1st stemless/anatomical prosthesis in multiple registries results [8,9,10]?​

To discover more on these milestones, check all the previous episodes here: Do you know? Enovis 1st worldwide innovations influencing shoulder arthroplasty... ​


BIBLIOGRAPHY
[1] Gasser B. Coating of the RM Cup. In Horne G, editor. The RM Cup – Long-term experience with an elastic Monoblock acetabular implant: Einhorn-presse Verlag; 2008. P23-30​
[2] Cuff DJ, Pupello DR, Santoni BG, Clark RE, Frankle MA. Reverse Shoulder Arthroplasty for the Treatment of Rotator Cuff Deficiency: A Concise Follow-up, at minimum of 10 years, of previous reports. J Bone Joint Surg Am. 2017 Nov 15;99(22):1895-1899​
[3] Holzwarth U, Cotogna G. Total Hip Artrhoplasty. State of The Art, Challenges and Prospects; JRC and policy reports, July 2012​
[4 ]Data on file at Mathys Ltd Bettlach​
[5] Latest ODEP ratings can be found at www.odep.org.uk​
[6] Auckland DC, Patel M, Knox D. Prosthesis design and placement in reverse total shoulder arthroplasty. J Orthop Surg Res. 2015 Jul 2;10:101​
[7] Delfosse D, Lerf R, Adlart C. What happens to the Vitamin E in a Vitamin-Stabilised HXLPE? EFFORT. 2014:197-205. ​
[8] Lewis PL, Gill DR, McAuliffe MJ, McDougall C, Stoney JD, Vertulo CJ, Wall CJ, Corfield S, Du P, Holder C, Harries D, Edwards S, Xu A, Lorimer MF, Cashman K, Smith PN. Hip, Knee and Shoulder Arthroplasty:2024 Annual Report, Australian Orthopaedic Association National Joint Replacement Registry, AOA:Adelaide, South Australia. 2024 https://doi.org/10.25310/GLOL7776; Table ST13 (Affinis Short)​
[9] National Joint Registry for England, Wales, Northern Ireland, the Isle of Man and Guernsey (NJR). 20th Annual Report 2024. Table 3.S5 (b) & (e), page 38 and 40. www.njrcentre.org.uk​
[10] National Joint Registry for England, Wales, Northern Ireland, the Isle of Man and Guernsey (NJR). Summary Report SP Humeral Affinis Short (Anatomic Total) 13.11.2024. Data valid to 13 November 2026​

Enovis 1st Worlwide Innovations influencing shoulder arthroplasty​